Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 201–250 of 671 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors	recruiting	Phase 2	200	Jazz PharmaceuticalsINDUSTRY	3	Jul 10, 2026	clinicaltrials
NCT07355205	First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer(FLINN)	recruiting	Phase 1 / Phase 2	26	Washington University School of MedicineOTHER	1	Jul 10, 2026